VERFAHREN ZUR HERSTELLUNG DES ACTAPLANINANTIBIOTIKUM-KOMPLEXES A-4696 MIT DEN FAKTOREN B TIEF 1, B TIEF 2, B TIEF 3, C TIEF 1 TIEF A, C TIEF 3 UND E TIEF 1
Antibiotic A-4696 factors B1, B2, B3, C1a, C3, and E1 are isolated from antibiotic A-4696, the latter being produced by Actinoplanes missouriensis strains ATCC 31680, ATCC 31682, and ATCC 31683 under submerged aerobic conditions in a culture medium and isolated from the fermentation broth by absorpt...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WEEKS,ROBERT E.,US COLE,HERALD J.,US DEBONO,MANUEL,US MERKEL,KURT E.,DE |
| description | Antibiotic A-4696 factors B1, B2, B3, C1a, C3, and E1 are isolated from antibiotic A-4696, the latter being produced by Actinoplanes missouriensis strains ATCC 31680, ATCC 31682, and ATCC 31683 under submerged aerobic conditions in a culture medium and isolated from the fermentation broth by absorption on an ion exchange resin and eluted therefrom at pH 10.5 with sodium hydroxide. The novel factors are separated by thin layer chromatography and high pressure liquid chromatography and have antimicrobial and growth promotant activity. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DD202048A5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DD202048A5</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DD202048A53</originalsourceid><addsrcrecordid>eNqFjEEOgjAURNm4MOoZ_AeABAGJLgv9lYZSSGmNcUOIqSujJHgbL6tEZOtqJvNeZu68jqgYyRRKOBsFGapaoxBGHoBiDSTVpBJEckmk5gkvNc9N4eVlUQk8DYIXxfsYCq4_vgRGcl0OZwlojgw27q8FUwtdSEf6DTINIRhJAUe6dGbX9tbb1ZgLZ81Qp5lnu0dj-6692Lt9NpQGfuBHO7IN_xtvrfk_Xw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VERFAHREN ZUR HERSTELLUNG DES ACTAPLANINANTIBIOTIKUM-KOMPLEXES A-4696 MIT DEN FAKTOREN B TIEF 1, B TIEF 2, B TIEF 3, C TIEF 1 TIEF A, C TIEF 3 UND E TIEF 1</title><source>esp@cenet</source><creator>WEEKS,ROBERT E.,US ; COLE,HERALD J.,US ; DEBONO,MANUEL,US ; MERKEL,KURT E.,DE</creator><creatorcontrib>WEEKS,ROBERT E.,US ; COLE,HERALD J.,US ; DEBONO,MANUEL,US ; MERKEL,KURT E.,DE</creatorcontrib><description>Antibiotic A-4696 factors B1, B2, B3, C1a, C3, and E1 are isolated from antibiotic A-4696, the latter being produced by Actinoplanes missouriensis strains ATCC 31680, ATCC 31682, and ATCC 31683 under submerged aerobic conditions in a culture medium and isolated from the fermentation broth by absorption on an ion exchange resin and eluted therefrom at pH 10.5 with sodium hydroxide. The novel factors are separated by thin layer chromatography and high pressure liquid chromatography and have antimicrobial and growth promotant activity.</description><edition>3</edition><language>ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; DERIVATIVES THEREOF ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; FODDER ; FOODS OR FOODSTUFFS ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; SPIRITS ; SUGARS ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES ; VINEGAR ; WINE</subject><creationdate>1983</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19830824&DB=EPODOC&CC=DD&NR=202048A5$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19830824&DB=EPODOC&CC=DD&NR=202048A5$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEEKS,ROBERT E.,US</creatorcontrib><creatorcontrib>COLE,HERALD J.,US</creatorcontrib><creatorcontrib>DEBONO,MANUEL,US</creatorcontrib><creatorcontrib>MERKEL,KURT E.,DE</creatorcontrib><title>VERFAHREN ZUR HERSTELLUNG DES ACTAPLANINANTIBIOTIKUM-KOMPLEXES A-4696 MIT DEN FAKTOREN B TIEF 1, B TIEF 2, B TIEF 3, C TIEF 1 TIEF A, C TIEF 3 UND E TIEF 1</title><description>Antibiotic A-4696 factors B1, B2, B3, C1a, C3, and E1 are isolated from antibiotic A-4696, the latter being produced by Actinoplanes missouriensis strains ATCC 31680, ATCC 31682, and ATCC 31683 under submerged aerobic conditions in a culture medium and isolated from the fermentation broth by absorption on an ion exchange resin and eluted therefrom at pH 10.5 with sodium hydroxide. The novel factors are separated by thin layer chromatography and high pressure liquid chromatography and have antimicrobial and growth promotant activity.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>FODDER</subject><subject>FOODS OR FOODSTUFFS</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1983</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjEEOgjAURNm4MOoZ_AeABAGJLgv9lYZSSGmNcUOIqSujJHgbL6tEZOtqJvNeZu68jqgYyRRKOBsFGapaoxBGHoBiDSTVpBJEckmk5gkvNc9N4eVlUQk8DYIXxfsYCq4_vgRGcl0OZwlojgw27q8FUwtdSEf6DTINIRhJAUe6dGbX9tbb1ZgLZ81Qp5lnu0dj-6692Lt9NpQGfuBHO7IN_xtvrfk_Xw</recordid><startdate>19830824</startdate><enddate>19830824</enddate><creator>WEEKS,ROBERT E.,US</creator><creator>COLE,HERALD J.,US</creator><creator>DEBONO,MANUEL,US</creator><creator>MERKEL,KURT E.,DE</creator><scope>EVB</scope></search><sort><creationdate>19830824</creationdate><title>VERFAHREN ZUR HERSTELLUNG DES ACTAPLANINANTIBIOTIKUM-KOMPLEXES A-4696 MIT DEN FAKTOREN B TIEF 1, B TIEF 2, B TIEF 3, C TIEF 1 TIEF A, C TIEF 3 UND E TIEF 1</title><author>WEEKS,ROBERT E.,US ; COLE,HERALD J.,US ; DEBONO,MANUEL,US ; MERKEL,KURT E.,DE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DD202048A53</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1983</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>FODDER</topic><topic>FOODS OR FOODSTUFFS</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>WEEKS,ROBERT E.,US</creatorcontrib><creatorcontrib>COLE,HERALD J.,US</creatorcontrib><creatorcontrib>DEBONO,MANUEL,US</creatorcontrib><creatorcontrib>MERKEL,KURT E.,DE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEEKS,ROBERT E.,US</au><au>COLE,HERALD J.,US</au><au>DEBONO,MANUEL,US</au><au>MERKEL,KURT E.,DE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VERFAHREN ZUR HERSTELLUNG DES ACTAPLANINANTIBIOTIKUM-KOMPLEXES A-4696 MIT DEN FAKTOREN B TIEF 1, B TIEF 2, B TIEF 3, C TIEF 1 TIEF A, C TIEF 3 UND E TIEF 1</title><date>1983-08-24</date><risdate>1983</risdate><abstract>Antibiotic A-4696 factors B1, B2, B3, C1a, C3, and E1 are isolated from antibiotic A-4696, the latter being produced by Actinoplanes missouriensis strains ATCC 31680, ATCC 31682, and ATCC 31683 under submerged aerobic conditions in a culture medium and isolated from the fermentation broth by absorption on an ion exchange resin and eluted therefrom at pH 10.5 with sodium hydroxide. The novel factors are separated by thin layer chromatography and high pressure liquid chromatography and have antimicrobial and growth promotant activity.</abstract><edition>3</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_DD202048A5 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE FODDER FOODS OR FOODSTUFFS HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS SPIRITS SUGARS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VINEGAR WINE |
| title | VERFAHREN ZUR HERSTELLUNG DES ACTAPLANINANTIBIOTIKUM-KOMPLEXES A-4696 MIT DEN FAKTOREN B TIEF 1, B TIEF 2, B TIEF 3, C TIEF 1 TIEF A, C TIEF 3 UND E TIEF 1 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A37%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEEKS,ROBERT%20E.,US&rft.date=1983-08-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDD202048A5%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |